As a result of concealing negative information about these psychiatric drugs and the promotional tactics by the drug makers of encouraging the off-label prescribing of the medications for so many different uses, experts say, tens of millions of people are now taking the medications without any valid indication for their use.
In fact, so many people are being prescribed these expensive drugs that the TMAP part of the marketing scheme is coming apart at the seams due to pure and simple greed. State lawmakers say that the costs incurred due to the over-prescribing of the drugs are bankrupting state Medicaid programs and they have to stop the practice of over-prescribing to keep from going broke.
According to the July 27, 2005, Wall Street Journal, antidepressants and antipsychotics are the third and fourth biggest classes of drugs in the US after cholesterol and heartburn medicines, with sales of $20.7 billion in 2004, with much "of that cost is borne by government health-care plans," the journal said.
The state of Georgia totally removed Zyprexa from its preferred drug list and any doctor who wants to start a Medicaid patient on Zyprexa, must now submit a clinical rationale stating why it's the only drug appropriate, according to the November 28, 2005, Indianapolis Business Journal.
Other states, including Tennessee, Illinois, Louisiana, and Pennsylvania also now require doctors to obtain prior authorization before prescribing Zyprexa to Medicaid patients, the Journal reports.
Big Pharma is making a ton of money off selling these drugs off-label for kids. A report in the April 24, 2005, Columbus Dispatch, found that 40,000 children aged 6-18 who were covered by Medicaid were prescribed psychotropic drugs: 31% of the children were in foster care, and 22% were in juvenile detention. Medicaid spent $65.5 million for drugs used primarily as "chemical restraints," according to Pyle, P, "Drugged into Submission."
According to FDA estimates, 11 million antidepressant prescriptions were written in 2003 for under 19-year-olds, representing a 27% increase in 3 years.
The sale of ADHD drugs, also skyrocked in 2003. In 5 to 9-year-old children their use increased 85%, and in preschoolers usage was up 49%, according to Medco Health Solution's, 2004 Drug Trend Symposium.
Overall, sales of psychiatric drugs totaled $26.7 billion in 2004, according to NDC Health Corp, a Georgia-based health information firm.
Information for injured parties can be found at Lawyers and Settlements.com
http://www.lawyersandsettlements.com/articles/pharma_business.html
Evelyn Pringle
evelyn.pringle@sbcglobal.net
Next Page 1 | 2 | 3 | 4 | 5 | 6 | 7
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).